TY - JOUR AU - Connolly, M. P. AU - Kotsopoulos, N. AU - Postma, M. J. AU - Bhatt, A. PY - 2017 DA - 2017// TI - The fiscal consequences attributed to changes in morbidity and mortality linked to Investments in Health Care: a government perspective analytic framework JO - Value Health VL - 20 UR - https://doi.org/10.1016/j.jval.2016.11.018 DO - 10.1016/j.jval.2016.11.018 ID - Connolly2017 ER - TY - JOUR AU - Kotsopoulos, N. AU - Connolly, M. P. PY - 2014 DA - 2014// TI - Is the gap between micro-and macroeconomic assessments in health care well understood? The case of vaccination and potential remedies JO - J Mark Access Health Policy VL - 2 UR - https://doi.org/10.3402/jmahp.v2.23897 DO - 10.3402/jmahp.v2.23897 ID - Kotsopoulos2014 ER - TY - JOUR AU - Connolly, M. P. AU - Baker, C. L. AU - Kotsopoulos, N. PY - 2018 DA - 2018// TI - Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework JO - J Med Econ VL - 21 UR - https://doi.org/10.1080/13696998.2018.1434183 DO - 10.1080/13696998.2018.1434183 ID - Connolly2018 ER - TY - STD TI - Health resources - Health spending - OECD Data [https://data.oecd.org/healthres/health-spending.htm]. Accessed 9 May 2019. UR - https://data.oecd.org/healthres/health-spending.htm ID - ref4 ER - TY - STD TI - Figari F, Paulus A, Sutherland H. Chapter 24 - microsimulation and policy analysis. In: Atkinson AB, Bourguignon F, editors. Handbook of Income Distribution, vol. 2: Elsevier; 2015. p. 2141–221. https://www.econstor.eu/bitstream/10419/197586/1/1040420044.pdf. UR - https://www.econstor.eu/bitstream/10419/197586/1/1040420044.pdf ID - ref5 ER - TY - JOUR AU - Abraham, J. M. PY - 2013 DA - 2013// TI - Using microsimulation models to inform U.S. health policy making JO - Health Serv Res VL - 48 UR - https://doi.org/10.1111/1475-6773.12052 DO - 10.1111/1475-6773.12052 ID - Abraham2013 ER - TY - JOUR AU - Schofield, D. AU - Shrestha, R. AU - Callander, E. AU - Percival, R. AU - Kelly, S. AU - Passey, M. AU - Fletcher, S. PY - 2011 DA - 2011// TI - Modelling the cost of ill health in health&WealthMOD (version II): lost labour force participation, income and taxation, and the impact of disease prevention JO - Int J Microsimulation VL - 4 ID - Schofield2011 ER - TY - CHAP AU - Richard Percival, A. A. AU - Quoc, N. AU - Gupta, A. ED - Harding, A. PY - 2007 DA - 2007// TI - Vu: Model 9: STINMOD (Static Incomes Model) BT - Modelling our future: population ageing health and aged care PB - Elsevier CY - Amsterdam; Boston ID - Richard Percival2007 ER - TY - JOUR AU - Auerbach, A. J. AU - Gokhale, J. AU - Kotlikoff, L. J. PY - 1994 DA - 1994// TI - Generational accounting: a meaningful way to evaluate fiscal policy JO - J Econ Perspect VL - 8 UR - https://doi.org/10.1257/jep.8.1.73 DO - 10.1257/jep.8.1.73 ID - Auerbach1994 ER - TY - JOUR AU - Michaud, P. -. C. AU - Goldman, D. AU - Lakdawalla, D. AU - Gailey, A. AU - Zheng, Y. PY - 2011 DA - 2011// TI - Differences in health between Americans and Western Europeans: effects on longevity and public finance JO - Soc Sci Med VL - 73 UR - https://doi.org/10.1016/j.socscimed.2011.05.027 DO - 10.1016/j.socscimed.2011.05.027 ID - Michaud2011 ER - TY - JOUR AU - Goldman, D. AU - Michaud, P. -. C. AU - Lakdawalla, D. AU - Zheng, Y. AU - Gailey, A. AU - Vaynman, I. PY - 2010 DA - 2010// TI - The fiscal consequences of trends in population health JO - Natl Tax J VL - 63 UR - https://doi.org/10.17310/ntj.2010.2.07 DO - 10.17310/ntj.2010.2.07 ID - Goldman2010 ER - TY - JOUR AU - Gertz, M. A. PY - 2017 DA - 2017// TI - Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges JO - Am J Manag Care VL - 23 ID - Gertz2017 ER - TY - JOUR AU - Ando, Y. AU - Coelho, T. AU - Berk, J. L. AU - Cruz, M. W. AU - Ericzon, B. -. G. AU - Ikeda, S. -. i. AU - Lewis, W. D. AU - Obici, L. AU - Planté-Bordeneuve, V. AU - Rapezzi, C. PY - 2013 DA - 2013// TI - Guideline of transthyretin-related hereditary amyloidosis for clinicians JO - Orphanet J Rare Dis VL - 8 UR - https://doi.org/10.1186/1750-1172-8-31 DO - 10.1186/1750-1172-8-31 ID - Ando2013 ER - TY - JOUR AU - Hanna, M. PY - 2014 DA - 2014// TI - Novel drugs targeting transthyretin amyloidosis JO - Curr Heart Fail Rep VL - 11 UR - https://doi.org/10.1007/s11897-013-0182-4 DO - 10.1007/s11897-013-0182-4 ID - Hanna2014 ER - TY - JOUR AU - Rowczenio, D. M. AU - Noor, I. AU - Gillmore, J. D. AU - Lachmann, H. J. AU - Whelan, C. AU - Hawkins, P. N. AU - Obici, L. AU - Westermark, P. AU - Grateau, G. AU - Wechalekar, A. D. PY - 2014 DA - 2014// TI - Online registry for mutations in hereditary amyloidosis including nomenclature recommendations JO - Hum Mutat VL - 35 UR - https://doi.org/10.1002/humu.22619 DO - 10.1002/humu.22619 ID - Rowczenio2014 ER - TY - JOUR AU - Shin, S. C. AU - Robinson-Papp, J. PY - 2012 DA - 2012// TI - Amyloid neuropathies JO - Mt Sinai J Med New York VL - 79 UR - https://doi.org/10.1002/msj.21352 DO - 10.1002/msj.21352 ID - Shin2012 ER - TY - JOUR AU - Conceição, I. AU - Carvalho, M. PY - 2007 DA - 2007// TI - Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal JO - Muscle Nerve VL - 35 UR - https://doi.org/10.1002/mus.20644 DO - 10.1002/mus.20644 ID - Conceição2007 ER - TY - JOUR AU - Denoncourt, R. N. AU - Adams, D. AU - Coelho, T. AU - Bettencourt, B. R. AU - Plaisted, A. AU - Amitay, O. AU - Falzone, R. AU - Harrop, J. AU - White, L. AU - Frutos, R. PY - 2015 DA - 2015// TI - Burden of illness for patients with familial amyloidotic polyneuropathy (Fap) begins early and increases with disease progression JO - Value Health VL - 18 UR - https://doi.org/10.1016/j.jval.2015.03.1672 DO - 10.1016/j.jval.2015.03.1672 ID - Denoncourt2015 ER - TY - JOUR AU - Stewart, M. AU - Shaffer, S. AU - Murphy, B. AU - Loftus, J. AU - Alvir, J. AU - Cicchetti, M. AU - Lenderking, W. R. PY - 2018 DA - 2018// TI - Characterizing the high disease burden of transthyretin amyloidosis for patients and caregivers JO - Neurol Ther VL - 7 UR - https://doi.org/10.1007/s40120-018-0106-z DO - 10.1007/s40120-018-0106-z ID - Stewart2018 ER - TY - JOUR AU - Klaassen, S. H. C. AU - Tromp, J. AU - Nienhuis, H. L. A. AU - Meer, P. AU - Berg, M. P. AU - Blokzijl, H. AU - Veldhuisen, D. J. AU - Hazenberg, B. P. C. PY - 2018 DA - 2018// TI - Frequency of and prognostic significance of cardiac involvement at presentation in hereditary transthyretin-derived amyloidosis and the value of N-terminal pro-B-type natriuretic peptide JO - Am J Cardiol VL - 121 UR - https://doi.org/10.1016/j.amjcard.2017.09.029 DO - 10.1016/j.amjcard.2017.09.029 ID - Klaassen2018 ER - TY - JOUR AU - Coelho, T. AU - Inês, M. AU - Conceição, I. AU - Soares, M. AU - Carvalho, M. AU - Costa, J. PY - 2018 DA - 2018// TI - Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy JO - Neurology VL - 91 UR - https://doi.org/10.1212/WNL.0000000000006543 DO - 10.1212/WNL.0000000000006543 ID - Coelho2018 ER - TY - JOUR AU - Castaño, A. AU - Drachman, B. M. AU - Judge, D. AU - Maurer, M. S. PY - 2015 DA - 2015// TI - Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs JO - Heart Fail Rev VL - 20 UR - https://doi.org/10.1007/s10741-014-9462-7 DO - 10.1007/s10741-014-9462-7 ID - Castaño2015 ER - TY - JOUR AU - Mauskopf, J. AU - Standaert, B. AU - Connolly, M. P. AU - Culyer, A. J. AU - Garrison, L. P. AU - Hutubessy, R. AU - Jit, M. AU - Pitman, R. AU - Revill, P. AU - Severens, J. L. PY - 2018 DA - 2018// TI - Economic analysis of vaccination programs JO - Value Health VL - 21 UR - https://doi.org/10.1016/j.jval.2018.08.005 DO - 10.1016/j.jval.2018.08.005 ID - Mauskopf2018 ER - TY - STD TI - StatLine - Employment; jobs, wages, working hours; key figures [https://opendata.cbs.nl/#/CBS/en/dataset/81431ENG/table?ts=1529671314235]. Accessed 9 May 2019. UR - https://opendata.cbs.nl/#/CBS/en/dataset/81431ENG/table?ts=1529671314235 ID - ref24 ER - TY - STD TI - StatLine - Labour participation; key figures [https://opendata.cbs.nl/#/CBS/en/dataset/82309ENG/table?ts=1529670397747]. Accessed 9 May 2019. UR - https://opendata.cbs.nl/#/CBS/en/dataset/82309ENG/table?ts=1529670397747 ID - ref25 ER - TY - STD TI - U hebt in 2018 de AOW-leeftijd nog niet bereikt [https://www.belastingdienst.nl/wps/wcm/connect/bldcontentnl/belastingdienst/prive/inkomstenbelasting/heffingskortingen_boxen_tarieven/boxen_en_tarieven/overzicht_tarieven_en_schijven/u-hebt-in-2018-de-aow-leeftijd-nog-niet-bereikt]. Accessed 9 May 2019. UR - https://www.belastingdienst.nl/wps/wcm/connect/bldcontentnl/belastingdienst/prive/inkomstenbelasting/heffingskortingen_boxen_tarieven/boxen_en_tarieven/overzicht_tarieven_en_schijven/u-hebt-in-2018-de-aow-leeftijd-nog-niet-bereikt ID - ref26 ER - TY - STD TI - StatLine - Inkomensverdeling van huishoudens; nr, 2005-2014. [https://opendata.cbs.nl/statline/#/CBS/nl/dataset/82959NED/table?ts=1532525633247]. Accessed 9 May 2019. UR - https://opendata.cbs.nl/statline/#/CBS/nl/dataset/82959NED/table?ts=1532525633247 ID - ref27 ER - TY - STD TI - Consumption Tax Trends 2016 - the Netherlands [https://www.oecd.org/tax/consumption/consumption-tax-trends-netherlands.pdf]. Accessed 9 May 2019. UR - https://www.oecd.org/tax/consumption/consumption-tax-trends-netherlands.pdf ID - ref28 ER - TY - STD TI - OECD. OECD Economic Surveys, vol. 2018. Netherlands: OECD Publishing; 2018. ID - ref29 ER - TY - STD TI - World Bank, Inflation, consumer prices for the Netherlands [FPCPITOTLZGNLD]. 2019. https://fred.stlouisfed.org/series/FPCPITOTLZGNLD. Accessed 9 May 2019. UR - https://fred.stlouisfed.org/series/FPCPITOTLZGNLD ID - ref30 ER - TY - STD TI - Wanneer krijgt u AOW | AOW | SVB [https://www.svb.nl/int/nl/aow/wat_is_de_aow/wanneer_aow/index.jsp]. Accessed 9 May 2019. UR - https://www.svb.nl/int/nl/aow/wat_is_de_aow/wanneer_aow/index.jsp ID - ref31 ER - TY - JOUR AU - Garattini, L. AU - Padula, A. PY - 2017 DA - 2017// TI - Dutch guidelines for economic evaluation:‘from good to better’in theory but further away from pharmaceuticals in practice? JO - J R Soc Med VL - 110 UR - https://doi.org/10.1177/0141076817690395 DO - 10.1177/0141076817690395 ID - Garattini2017 ER - TY - STD TI - PAID - iMTA [https://www.imta.nl/paid]. Accessed 9 May 2019. UR - https://www.imta.nl/paid ID - ref33 ER - TY - JOUR AU - Baal, P. H. AU - Wong, A. AU - Slobbe, L. C. AU - Polder, J. J. AU - Brouwer, W. B. AU - Wit, G. A. PY - 2011 DA - 2011// TI - Standardizing the inclusion of indirect medical costs in economic evaluations JO - PharmacoEconomics VL - 29 UR - https://doi.org/10.2165/11586130-000000000-00000 DO - 10.2165/11586130-000000000-00000 ID - Baal2011 ER - TY - STD TI - CBS Statline [https://opendata.cbs.nl/statline/#/CBS/nl/dataset/82959NED/table?ts=1532525633247]. Accessed 9 May 2019. UR - https://opendata.cbs.nl/statline/#/CBS/nl/dataset/82959NED/table?ts=1532525633247 ID - ref35 ER - TY - STD TI - Mijn geldzaken tijdens WAO | UWV | Particulieren [https://www.uwv.nl/particulieren/ziek/ziek-wao-uitkering/geldzaken-tijdens-wao/detail/hoogte-en-duur-van-een-wao-uitkering/arbeidsongeschiktheidsklasse-bij-wao]. Accessed 9 May 2019. UR - https://www.uwv.nl/particulieren/ziek/ziek-wao-uitkering/geldzaken-tijdens-wao/detail/hoogte-en-duur-van-een-wao-uitkering/arbeidsongeschiktheidsklasse-bij-wao ID - ref36 ER - TY - JOUR AU - Adams, D. PY - 2012 DA - 2012// TI - Recent advances in the treatment of familial amyloid polyneuropathy JO - Ther Adv Neurol Disord VL - 6 UR - https://doi.org/10.1177/1756285612470192 DO - 10.1177/1756285612470192 ID - Adams2012 ER - TY - JOUR AU - Adams, D. AU - Suhr, O. B. AU - Hund, E. AU - Obici, L. AU - Tournev, I. AU - Campistol, J. M. AU - Slama, M. S. AU - Hazenberg, B. P. AU - Coelho, T. PY - 2016 DA - 2016// TI - First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy JO - Curr Opin Neurol VL - 29 UR - https://doi.org/10.1097/WCO.0000000000000289 DO - 10.1097/WCO.0000000000000289 ID - Adams2016 ER - TY - JOUR AU - Nienhuis, H. L. A. AU - Bijzet, J. AU - Hazenberg, B. P. C. PY - 2016 DA - 2016// TI - The prevalence and Management of Systemic Amyloidosis in Western countries JO - Kidney Dis (Basel, Switzerland) VL - 2 ID - Nienhuis2016 ER - TY - JOUR AU - Annemans, L. AU - Ayme, S. AU - Cam, Y. AU - Facey, K. AU - Gunther, P. AU - Nicod, E. AU - Reni, M. AU - Roux, J. L. AU - Schlander, M. AU - Taylor, D. PY - 2017 DA - 2017// TI - Recommendations from the European working Group for Value Assessment and Funding Processes in rare diseases (ORPH-VAL) JO - Orphanet J Rare Dis VL - 12 UR - https://doi.org/10.1186/s13023-017-0601-9 DO - 10.1186/s13023-017-0601-9 ID - Annemans2017 ER - TY - JOUR AU - Schey, C. AU - Krabbe, P. F. M. AU - Postma, M. J. AU - Connolly, M. P. PY - 2017 DA - 2017// TI - Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs JO - Orphanet J Rare Dis VL - 12 UR - https://doi.org/10.1186/s13023-016-0555-3 DO - 10.1186/s13023-016-0555-3 ID - Schey2017 ER - TY - JOUR AU - Gutierrez, L. AU - Patris, J. AU - Hutchings, A. AU - Cowell, W. PY - 2015 DA - 2015// TI - Principles for consistent value assessment and sustainable funding of orphan drugs in Europe JO - Orphanet J Rare Dis VL - 10 UR - https://doi.org/10.1186/s13023-015-0269-y DO - 10.1186/s13023-015-0269-y ID - Gutierrez2015 ER - TY - STD TI - Social Protection Statistics 2015 [https://ec.europa.eu/eurostat/statistics-explained/index.php/Social_protection_statistics#Social_protection_expenditure_and_GDP_rates_of_change]. Accessed 9 May 2019. UR - https://ec.europa.eu/eurostat/statistics-explained/index.php/Social_protection_statistics#Social_protection_expenditure_and_GDP_rates_of_change ID - ref43 ER - TY - STD TI - State of Health in the EU Netherlands Country Health Profile 2017 [https://ec.europa.eu/health/sites/health/files/state/docs/chp_nl_english.pdf]. Accessed 9 May 2019. UR - https://ec.europa.eu/health/sites/health/files/state/docs/chp_nl_english.pdf ID - ref44 ER - TY - JOUR AU - Connolly, M. P. AU - Kotsopoulos, N. AU - Ustianowski, A. PY - 2018 DA - 2018// TI - Modeling the fiscal costs and benefits of alternative treatment strategies in the United Kingdom for chronic hepatitis C JO - J Med Econ VL - 21 UR - https://doi.org/10.1080/13696998.2017.1371032 DO - 10.1080/13696998.2017.1371032 ID - Connolly2018 ER -